Д.Цэнд-Аюуш
Loading...
Товч нэр
Д.Цэнд-Аюуш
Бүтэн нэр
Дамба Цэнд-Аюуш
Латин нэр
Damba Tsend-Ayush
Албан тушаал
Захирал
Эрдмийн цол
Профессор
Боловсролын зэрэг
Доктор (Ph.D)
5 results
Now showing 1 - 5 of 5
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Topical Meconium Improves Barrier Repair and Reduces Skin Inflammation in a Rat Model of Eczema(2025-12-15) ;Anudari Ichinkhorloo ;Khuslen Batzorig; ;Batbold BatsaikhanEczema, or atopic dermatitis, is a chronic inflammatory skin condition characterized by epidermal barrier dysfunction and immune dysregulation. While traditionally considered a waste product, meconium—the first stool of neonates—contains various bioactive compounds that may influence immune responses and epithelial integrity. This study investigates the dermatological effects of meconium in a chemically induced eczema model in Wistar rats, focusing on its potential to modulate inflammation and promote skin barrier repair. Meconium samples were collected from healthy neonates and applied topically to rats with Veet-induced eczema. The experimental groups included untreated eczema controls, meconium-treated rats, Meebo ointment-treated rats (positive control), and a healthy control group. Clinical assessments of erythema, ulceration, and edema were conducted, alongside histopathological evaluations of epidermal thickness and immune cell infiltration. Statistical analyses were performed using ANOVA with post-hoc Tukey tests. Meconium treatment significantly reduced erythema and ulceration scores compared to untreated eczema controls (p<0.01) and increased epidermal thickness (p<0.05). While less effective than Meebo ointment, meconium demonstrated notable anti-inflammatory and regenerative properties. The findings suggest that meconium contains bioactive components capable of modulating skin inflammation and enhancing barrier repair, warranting further investigation into its potential therapeutic applications in dermatological conditions. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Topical Meconium Improves Barrier Repair and Reduces Skin Inflammation in a Rat Model of Eczema(2025-12-30) ;Anudari Ichinkhorloo ;Khuslen Batzorig; ;Batbold BatsaikhanEczema, or atopic dermatitis, is a chronic inflammatory skin condition characterized by epidermal barrier dysfunction and immune dysregulation. While traditionally considered a waste product, meconium—the first stool of neonates—contains various bioactive compounds that may influence immune responses and epithelial integrity. This study investigates the dermatological effects of meconium in a chemically induced eczema model in Wistar rats, focusing on its potential to modulate inflammation and promote skin barrier repair. Meconium samples were collected from healthy neonates and applied topically to rats with Veet-induced eczema. The experimental groups included untreated eczema controls, meconium-treated rats, Meebo ointment-treated rats (positive control), and a healthy control group. Clinical assessments of erythema, ulceration, and edema were conducted, alongside histopathological evaluations of epidermal thickness and immune cell infiltration. Statistical analyses were performed using ANOVA with post-hoc Tukey tests. Meconium treatment significantly reduced erythema and ulceration scores compared to untreated eczema controls (p<0.01) and increased epidermal thickness (p<0.05). While less effective than Meebo ointment, meconium demonstrated notable anti-inflammatory and regenerative properties. The findings suggest that meconium contains bioactive components capable of modulating skin inflammation and enhancing barrier repair, warranting further investigation into its potential therapeutic applications in dermatological conditions. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Topical Meconium Improves Barrier Repair and Reduces Skin Inflammation in a Rat Model of Eczema(2025-12-15) ;Anudari Ichinkhorloo ;Khuslen Batzorig; ;Batbold BatsaikhanEczema, or atopic dermatitis, is a chronic inflammatory skin condition characterized by epidermal barrier dysfunction and immune dysregulation. While traditionally considered a waste product, meconium—the first stool of neonates—contains various bioactive compounds that may influence immune responses and epithelial integrity. This study investigates the dermatological effects of meconium in a chemically induced eczema model in Wistar rats, focusing on its potential to modulate inflammation and promote skin barrier repair. Meconium samples were collected from healthy neonates and applied topically to rats with Veet-induced eczema. The experimental groups included untreated eczema controls, meconium-treated rats, Meebo ointment-treated rats (positive control), and a healthy control group. Clinical assessments of erythema, ulceration, and edema were conducted, alongside histopathological evaluations of epidermal thickness and immune cell infiltration. Statistical analyses were performed using ANOVA with post-hoc Tukey tests. Meconium treatment significantly reduced erythema and ulceration scores compared to untreated eczema controls (p<0.01) and increased epidermal thickness (p<0.05). While less effective than Meebo ointment, meconium demonstrated notable anti-inflammatory and regenerative properties. The findings suggest that meconium contains bioactive components capable of modulating skin inflammation and enhancing barrier repair, warranting further investigation into its potential therapeutic applications in dermatological conditions. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Using Network Pharmacology to Clarify the Therapeutic Mechanism of Hataagqi-19 Hot Compress Therapy in Rats with Lumbar Disc Herniation(Mongolian National University of Medical Sciences, 2021-07-01) ;Aruhan ;Byambasuren Dorjsuren ;Chimedragchaa ChimedtserenObjective: This study aims to determine the primary efficacy of traditional medicine treatment of Lumbar disc herniation (LDH) and the effect of Hataagqi-19 hot compress (H19+HC) therapy on LDH rats. Methods: Referencing ancient books of Mongolian medicine, we studied the theoretical basis of Mongolian medicine to treat LDH. We performed operations to establish a model of SD rats with LDH treated with H19+HC. Paw withdrawal threshold (PWT) was detected, serum TNF-α, IL-6, and IL-1β were measured by ELISA, and immunohistochemical staining was used to measure IL-6, CD68, and IgG. Results: The medicinal properties of the drugs for the treatment of LDH are mainly dry “Xieriwusu,” heat-clearing, and suppressing “Heyi” medicine. The PWT value, serum TNF-α, IL-6, IL-1β and tissue IL-6, CD68, IgG of H19+HC was lower than that of the control group. The nucleus pulposus of the H19+HC was significantly smaller than that of the control group. The positive staining result in the main inflammatory cells of the lesion was CD68. Conclusions: Mongolian medicine treatment of LDH is based on the dry “Xieriwusu,” heat-clearing, and suppressing “Heyi” efficacy. The H19+HC therapy follows this efficacy and has the effects of improved abnormal behavior, analgesic, anti-inflammatory, and reabsorption of the nucleus pulposus. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Effect of Panzeria Alaschanica Kupr. on Carrageenan-Induced Acute Inflammation in Rats(Mongolian National University of Medical Sciences, 2023-09-30) ;Hu Bi Si Ha La Tu ;Khaliunaa Tumurbaatar ;Chimedragchaa Chimedtseren; Objectives: In the present study, we aimed to investigate the effect of Panzeria alaschanica Kupr. (P. alaschanica) on carrageenan-induced acute inflammation in rats. Method: Carrageenan-induced rat paw edema was used to evaluate the anti-inflammatory activity. P. alaschanica extract (32, 64, and 160 mg/kg/ BW) or vehicle was given orally 60 minutes before the subplantar injection of carrageenan. Ibuprofen (100 mg/kg) was used as a standard drug. The carrageenan-injected paw was measured 30, 60, 120, 180, and 240 minutes after the carrageenan injection. The levels of serum tumor necrosis factor (TNF)-α, interleukin (IL)-ELISA measured 1β, and IL-6. Results: The P. alaschanica at all given doses significantly (p˂0.01) inhibited carrageenan-induced rat paw edema. Moreover, it significantly reduced TNF-α, IL-1β, and IL-6 serum levels at different doses (p˂0.01). The anti-inflammatory effect of P. alaschanica was comparable to ibuprofen. Conclusion: P. alaschanica has an anti-inflammatory impact on carrageenan-induced paw edema in rats. The mechanism of action may partly be via reducing the levels of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6.
